Intrinsiqs

Is Castle Biosciences, Inc. overvalued?

Castle Biosciences, Inc. (CSTL) — key valuation metrics and fundamentals.

No verdict
Price
$29.62
Fair value
Current P/E
Normal P/E
Market cap
$904.9M
Dividend yield
0.0%
Return on equity
-4.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CSTL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.